Integrated multi-omics analysis identifies DARS2, MRTO4, and MRPL37 as novel biomarkers and potential therapeutic targets for bladder cancer
{{output}}
Background: Bladder cancer (BC) is the predominant malignant tumor in the urinary system globally, with its intricate molecular features greatly influencing patient outcomes and treatment response.Identifying novel biomarkers and... ...
